Interim data from
approximately 40 subjects in Voyager's complementary Phase II study in men
will be available soon thereafter.
"We are grateful for the work done by our clinical trial sites and very
optimistic about what the data will show," said Patrick S. The company expects to have many of these programs moved to the
clinic by the end of 2005. Additional information is available at Voyager's
website , http://www.
FOR MORE INFORMATION ABOUT MIGRAINE, TREATMENT OPTIONS AND THE NEW "MIND
OVER MIGRAINE" PROGRAM, VISIT http://WWW. With the discovery of an increased risk of cardiovascular events
affecting popular COX-2 inhibitors, opioids provide an important and viable
substitute for pain management.html. DeVito, Sr.

understandings grimshaw

yorktown geriatrics

Voyager Pharmaceutical Corp. Completes Phase II Clinical Study For Alzheimer 's Disease

Richard L."

"MIND OVER MIGRAINE" RESOURCES INCLUDE AN EDUCATIONAL BOOKLET ABOUT
MIGRAINE AND PREVENTION MEDICATION, DIARY, AND A WEB SITE OFFERING MIGRAINE
MANAGEMENT TIPS AND INFORMATION. This article will help the clinician determine
when to use NSAIDs and which medications of this type may be better options
for use in conjunction with opioids.

preparing longevity

The company's scientific platform is based on the
peer reviewed published work of Dr., An article published today in the
new Journal of Opioid Management suggests that opioids are an alternative for
COX-2 selective nonsteroidal anti-inflammatory drugs (NSAIDs), when used
properly.com/cox2.

leonid senescence

S. We are also enthused about the fact that 90 percent of the Phase
II completers have chosen to continue their participation in the extension
study., brain cancer,
Parkinson's disease and improving the post-natal development of premature
infants.
Opioids are often used in combination with other analgesics, NSAIDs in
particular. Enck, MD, is designed to provide doctors with
important information regarding the use and management of opioids. "There is a
wide chasm between physician and nurse understanding of opioid use and pain
management in general," said Dr.

gerontological helpful

longevity gerontology

Voyager plans to present the findings from
these two studies, along with the bioavailability data from human trials using
its patented implant , to the Food and Drug Administration (FDA) in mid-2005. Smith, President
and CEO, Voyager Pharmaceutical Corp. Voyager was founded in March
2000 to focus on a treatment for Alzheimer's disease and is funded entirely by
high net worth individuals, with no institutional investors.
Voyager's Invention Center, headed by Dr.
The Journal of Opioid Management, a new bimonthly publication led by
Editor -in-Chief Robert E.

recommendations longevity

announced today the completion of its 48-week Phase II Alzheimer's disease
study - a major clinical achievement for the biopharmaceutical company focused
on diseases of aging and development.
THIS CAMPAIGN, SPONSORED BY ORTHO-MCNEIL NEUROLOGICS, OFFERS PRACTICAL
TOOLS AND A COMPREHENSIVE APPROACH THAT WILL HELP PEOPLE MAKE LIFESTYLE
MODIFICATIONS AND FIND THE RIGHT MEDICATION TO MANAGE THEIR MIGRAINE ATTACK."
The article abstract can be accessed online at
http://www .
781-899-2702 x142
radsr@pnpco.

longevity yorktown

Voyager expects to receive the
results of the double blind study in the next few weeks. "Hopefully, the
Journal of Opioid Management can close this gap .opioidmanagement.

senescence authority

"We expect the clinical endpoints to be
consistent with our expectations and bring us closer to delivering a new
medication for the millions of Alzheimer's patients in the U. Christopher Gregory is
conducting preclinical work in prostate cancer, A.

specialties geriatrics

roy extension

New 'Mind Over Migraine' Program Helps People With Migraine Get On Track to Better Health

com.

recommendations walford

Bowen, Voyager's Chief
Scientific Officer and one of Voyager's founders.L. LODER ENCOURAGES PEOPLE WITH MIGRAINE TO WORK IN PARTNERSHIP WITH
THEIR DOCTORS TO CREATE A TREATMENT PLAN THAT'S RIGHT FOR THEM.

researcher senescence

com . WESTON, Mass.com

researcher extension

, Voyager Pharmaceutical Corp.voyagerpharma.

grimshaw recommendations

"

About Voyager Pharmaceutical Corporation
Voyager Pharmaceutical Corporation is a biopharmaceutical organization
dedicated to "Cures for Mankind" that is strategically focused on diseases of
aging and development.

senescence helpful

NEW YORK,

STORY INFORMATION:

THIS IS A MULTIVU SPECIAL REPORT.

DR.MINDOVERMIGRAINE.

understandings researcher

gerontological aging

specialties grimshaw

and international pivotal studies in September 2005. and throughout
the world.

extension researcher

C.
The double blind, placebo controlled multi-center trial enrolled 109
female Alzheimer's disease patients in 2003.COM OR CALL 1-800-617 -1144.

nutrition grimshaw

When the lines of communication between
a patient and doctor are open, the result tends to be a more satisfying,
effective approach to migraine management.

gerontology understandings

DOCTOR ELIZABETH LODER of the Harvard Medical School Headache Management
Program/Spaulding Rehabilitation Hospital:
"Through 'Mind Over Migraine' we're providing people with resources to
help them partner with their doctor.

Opioids are Alternative for COX-2 Pain Medications

Enck, who also holds the same position with
the American Journal of Hospice and Palliative Medicine. The Journal of Opioid Management is
located at 470 Boston Post Road, Weston MA 02493, and can be contacted at 781-
899-2702, or http: //www.opioidmanagement.

roy nutrition

90 Percent of Subjects Elect to Enroll in Extension Study

RALEIGH, N.
A favorable review of this submission will facilitate the commencement of U.S.
A NEW EDUCATIONAL INITIATIVE, "MIND OVER MIGRAINE," CAN HELP MILLIONS OF
PEOPLE WITH MIGRAINE REACH THEIR GOALS OF LEADING A HEALTHIER LIFE, INCLUDING
A LIFE WITH FEWER MIGRAINE ATTACKS.

AUDIO PROVIDED BY: Ortho-McNeil Neurologics

leonid aging

Contact for further info:
Richard A.